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CASE REPORT
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Key Clinical Message
A change in clinical behavior of a disease should prompt search for differential
diagnoses. Here, the appearance of ulcerated skin nodules in a preexisting cuta-
neous mastocytosis revealed a concurrent lymphomatoid papulosis – a CD30+
lymphoproliferative skin disease with histological features of a malignant lym-
phoma, but with a benign self-healing course.
Keywords
Lymphomatoid papulosis, mastocytosis, urticaria pigmentosa.
A 10-year-old boy presented at the age of 12 months with
a gradual onset of small, brown elements on the trunk
and extremities (Fig. 1A). Rubbing of the lesions resulted
in a wheal and flare reaction (Darier’s sign) and the diag-
nosis of maculopapular cutaneous mastocytosis was con-
firmed histologically by the demonstration of infiltrates of
tryptase-positive MCs in lesional skin. The KIT D816V
mutation was not detectable in blood or skin. Routine
laboratory investigations were normal including a low
basal serum-tryptase (3.0 lg/L). During the course symp-
toms have been mild, and treatment not necessary. A
gradual fading of skin lesions has been observed. In addi-
tion to mastocytosis the child also had an early history of
milk and egg allergy, atopic dermatitis, and mild asthma.
From the age of 9 years a new type of skin lesions
appeared, consisting of 3–5 mm symmetrically distributed,
scaly papules mainly on the extremities (Fig. 1B). Some of
the elements were ulcerated with crust formation. Physical
examination was unremarkable and complete blood cell
count, creatinine, liver function tests and serum-tryptase
were all normal. A punch biopsy from lesional skin
showed a pleomorphic CD30-positive T-cell lymphocytic
infiltrate with hardly any MCs (Fig. 2). A T-cell receptor
gene rearrangement (TCR) analysis showed clonality,
whereas as the KIT D816V mutation was not detectable in
these skin lesions. These features confirmed the diagnosis
lymphomatoid papulosis (LyP). Treatment with potent
topical steroid was initiated with a slow response. After
the initial outbreak, recurrent crops of skin lesions were
seen, however, lesions were fewer, smaller, and occurred
less frequently. Over 1 year a significant improvement has
been observed and the child is thriving well. Hematologic
parameters and objective exams have been unremarkable.
Treatment with methotrexate has been considered but so
far not found indicated.
Discussion
To our knowledge, this is the first report on concomitant
LyP and mastocytosis. Even though both diseases are rare
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and may display features of clonality, it is possible that
the present concurrence should be regarded as fortuitous.
The true prevalence of pediatric mastocytosis is not
known, but estimated to be similar to adult mastocytosis
and around 10 in 100.000 [1]. Whereas adult mastocyto-
sis is almost always a systemic disease with a clonal prolif-
eration of neoplastic MCs caused by the somatic KIT
D816V mutation, pediatric mastocytosis is mostly limited
to the skin and 80–90% of affected children exhibit a
spontaneous remission before puberty [2]. The KIT
D816V mutation can only be detected in 25–35% of
affected children [3], however, mutations in KIT outside
exon 17 are reportedly prevalent, indicating that pediatric
mastocytosis in many cases is a clonal disease associated
with somatic mutations in KIT [4].
LyP is classified among CD30+ cutaneous lymphopro-
liferative diseases [5]. The prevalence of LyP have been
estimated to be 1.2–1.9 per million in adults [6]. Pediatric
cases have rarely been described and reportedly associated
with atopy in up to 60% [7], as also found in the present
case. Clinically it is characterized by recurrent crops of
erythematous papules and nodules that resolve after
weeks to months, leaving atrophic scars.
Potential differential diagnoses in childhood include
insect bites, pityriasis lichenoides (PL), and CD30-posi-
tive, anaplastic large T-cell lymphoma among others. Dif-
ferentiating LyP from skin lesions caused by insects is
usually straightforward clinically as well as histologically.
Skin lesions in PL are usually smaller and of shorter dura-
tion than LyP and histologically, lichenoid infiltrates
without CD30-positive T lymphocytes are usually seen,
but in atypical cases a clear distinction between LyP and
PL may be difficult to make. An important and some-
times difficult differential diagnosis of LyP, type C is
CD30-positive anaplastic large T-cell lymphoma, and in
rare cases the histological distinction is impossible and
clinical course decisive.
In adult patients a malignant transformation has been
described with mycosis fungoides, Hodgkin lymphoma
and CD30 positive large-cell lymphoma being most
common. In pediatric LyP the absolute risk for
(A) (B)
Figure 1. A: Discrete mastocytosis skin lesions (urticaria pigmentosa) with small reddish-brown elements distributed over the trunk at the age of
2 years. B: Lymphomatoid papulosis lesions with ulceration and crusting on the patients right arm at the age of 9 years.
CD30
Figure 2. Punch biopsy from the arm of the patient. Throughout the
dermis there is a diffuse, dense lymphocytic infiltrate of large cells
with pleomorphic nuclei and prominent nucleoli (close up, left inset).
The large cells are CD30 positive T lymphocytes (right inset). The
epidermis is uninvolved.
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transformation is estimated to be very low, however, has
rarely been reported, for example, by Nijsten and col-
leagues who described development of non-Hodgkin lym-
phoma in 3 of 35 children with LyP [7]. Thus, a follow-
up in line with adults is recommended [5].
In the present case we did not detect evidence of asso-
ciations between the pre-existing mastocytosis and devel-
opment of LyP. Cellular lineages involved differ, and we
did not detect histologic signs of MC infiltration in the
LyP skin lesions.
In summary, we report a unique case of a child with
concomitant LyP and cutaneous mastocytosis. Both dis-
eases are rare and have to our knowledge not been
reported together before. Even though it seems probable
that the two conditions occurred together by chance fur-
ther studies are needed to elucidate if any associations
between LyP and mastocytosis exist.
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